In focus · trending topic

Parkinson’s disease

2 stories · following the connections

Small Psilocybin Study Links Treatment With Lower Inflammation Markers

By Naomi CalderOct 22, 2026, 1:37 AM UTC

XellSmart Says It Completed Enrollment in Phase II Parkinson’s Trial

By Naomi CalderOct 18, 2026, 4:46 AM UTC